April 11, 2022
...

Genome Sequencing

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and contains information on how the organism develops, functions, and replicates or reproduces. Sequencing the genome of an organism whether it is human, bacteria or virus is an important step towards understanding it. Currently available advanced sequencing technologies can sequence the genome of an organism in the time span of a few hours to a few days depending on the size of the genome. For example, the SARS-CoV-2 virus genome is 30 kilo bases, that includes ~ 12 genes whereas human genome is 3 billion base pairs that includes ~ 30,000 genes. Therefore, the SARS-CoV-2 genome is much smaller than the human genome and can be sequenced much faster.

 

SARS-Cov-2 Variants

Genome sequencing is a vital tool that is currently being used to identify and track new emerging SARS-CoV-2 variants. SARS-CoV-2 is an RNA virus that mutates at a rapid rate. Accumulation of these mutations or changes results in a new lineage or sub-lineage of the virus. It is important to note that lot of mutations arise as a virus replicates and evolves over time but most of these mutations have no impact on a variant’s ability to spread or cause infection. However, some mutations that occur on key areas of the genome may give it an advantage like increased transmissibility, enhanced virulence, or allow it to evade recognition by the immune system. For example, spike protein of SARS-CoV-2 directly interacts with receptors on human cells to get entry into cells and cause infection so mutations on the spike protein gene are important and may lead to new lineages. These new lineages commonly called COVID variants have a slightly different genome sequence from their parent’s lineage and have different biological characteristics as well.

 

Next Generation Sequencing (NGS)

To perform genome sequencing, first genetic material of the virus is isolated from the patient specimen, and then the next generation sequencing (NGS) library is prepared followed by sequencing on genome analyzers called sequencers. Then, genome sequences are processed using bioinformatics analyses and assigned a Pango lineage using the web-based pangolin tool (1). This allows identification and tracking of COVID variants in different geographical regions especially variants that show evidence of clinical significance and are classified as variant of concern (VOC). So far, COVID variants that have been classified as VOCs are B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta), and B.1.1.529 (Omicron).

 

Surveillance  

Since the start of the pandemic, scientists and public health officials have been using genomic surveillance to track new variants and understand how they are being transmitted in the local communities and globally. This kind of information is very useful for public health officials in order to best update public health and travel guidelines, make recommendations to minimize spread of infection and maximize resource allocation. It is crucial that genomic sequence data is made publicly available immediately to guide public health authorities to develop interventions and recommendations for the public in timely manner. The knowledge of new mutations in key regions of the genome is very useful for vaccine developers and scientists to design new vaccines and assess how well available vaccines work on new variants. It could also potentially assist in redesigning available vaccines so that they could better target the emerging variants.

 

More Variants Emerge

One big question is whether more variants will emerge in the future or if Omicron is the last variant in this pandemic. It is hard for epidemiologists or public health authorities to predict that but considering SARS-CoV-2 is an RNA virus that mutates at a fast rate, it is likely that there will be new variants. One of the characteristics of viruses is that they need host cells to replicate and mutate, therefore they evolve over time. If vaccination rates are high and transmission rates are low, there are fewer opportunities for the virus to replicate and mutate. This slows down evolution of virus and reduces risk of new variants.

Genome sequencing has and will continue to be a vital tool in the fight against SARS-CoV-2.

 
References:

  1. https://cov-lineages.org/resources/pangolin.html

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.

What's New

April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More
October 13, 2021

CTGT.net: A New Website Experience

We've refreshed our look and feel to better meet your needs. 

CTGT's new website is not only user-friendly but also provides more advanced test search capabilities, additional methodologies, and a clean design suited for multi-platform usage.

Read More
September 28, 2021

9 New Tests for Genetic Carrier Screening Panels

CTGT is now offering 9 NEW tests for Genetic Carrier Screening. 
Read More
September 25, 2021

New York State Clinical Laboratory Permit Approval

CTGT is proud to announce that its CLIA licensed and CAP-accredited Pennsylvania laboratory has earned a New York State Department of Health clinical laboratory permit to perform genetic testing for patients residing within the state of New York. 
Read More